
|Articles|November 1, 2004
Intensive post-Tx cancer surveillance often unneeded
San Francisco-Urologists need to become more frugal in monitoring patients after urologic cancer treatment, advises Steven C. Campbell, MD, PhD, associate professor and co-director of urologic oncology at Loyola University Medical Center, Maywood, IL.
Advertisement
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
FDA approves sildenafil oral film for men with erectile dysfunction
2
The UroOnc Minute: Adjuvant Therapy in Renal Cell Carcinoma, with Brian Shuch, MD
3
Head-to-head analysis shows OS benefit with apalutamide vs darolutamide in mCSPC
4
Phase 1/2 trial launches of molecular glue degrader for ccRCC
5






